The Health-Tech Podcast #111: The Story of Unlearn.ai with Charles Fisher

Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology and is the founder of Unlearn.ai . Previously, Charles worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at École Normale Supérieure in Paris, France, and a postdoctoral scientist in biophysics at Boston University. Charles holds a Ph.D. in biophysics from Harvard University and a B.S. in biophysics from the University of Michigan.


Unlearn creates Digital Twins to populate Intelligent Control Arms in clinical studies. While others leverage existing data, Unlearn generates a new type of data, for any type of patient. A Digital Twin is a longitudinal, computationally generated clinical record that describes what would have happened if a specific patient received a placebo.

https://www.linkedin.com/in/drckf/ | www.unlearn.ai

Get in touch:

www.jamessomauroo.com | www.somx.co.uk

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

AD/PD 2021: Unlearn will present novel, AI-driven approaches to enabling smaller, more efficient Alzheimer’s clinical trials

Press

How Digital Twin Technology is Disrupting Healthcare

Press

Next-gen digital health innovation in clinical trials

The Rock Health team reflects on the evolution of digital in clinical trials, discuss the current state, and explore the opportunity to further transform drug discovery.
The use of digital twins in the healthcare industry is revolutionizing clinical processes.
Join us at The 15th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, March 9 - 14, 2021.